HemaSphere (Aug 2023)
P923: COMPARATIVE EFFECTIVENESS OF TALQUETAMAB VS REAL-WORLD PHYSICIAN’S CHOICE OF TREATMENT IN LOCOMMOTION AND MOMMENT FOR PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA
- Hermann Einsele,
- Philippe Moreau,
- Nizar J Bahlis,
- Manisha Bhutani,
- Laure Vincent,
- Lionel Karlin,
- Aurore Perrot,
- Hartmut Goldschmidt,
- Niels W.C.J. van de Donk,
- Enrique Ocio,
- Joaquín Martinez-Lopez,
- Paula Rodríguez-Otero,
- Dominik Dytfeld,
- Joris Diels,
- Vadim Strulev,
- Imene Haddad,
- Thomas Renaud,
- Eric Ammann,
- Jedelyn Cabrieto,
- Nolen Perualila,
- Ryan Gan,
- Youyi Zhang,
- Trilok Parekh,
- Claire Albrecht,
- Katja Weisel,
- Maria-Victoria Mateos
Affiliations
- Hermann Einsele
- 1 Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany
- Philippe Moreau
- 2 Hematology Clinic, University Hospital Hotel-Dieu, Nantes, France
- Nizar J Bahlis
- 3 Arnie Charbonneau Cancer Institute, Calgary, Canada
- Manisha Bhutani
- 4 Levine Cancer Institute/Atrium Health, Charlotte, United States
- Laure Vincent
- 5 Département d’hématologie Clinique, Centre Hospitalier Universitaire de Montpellier, Montpellier, France
- Lionel Karlin
- 6 Centre Hospitalier Lyon, Sud, France
- Aurore Perrot
- 7 Centre Hospitalier Universitaire de Toulouse, Service d’Hématologie, Toulouse, France
- Hartmut Goldschmidt
- 8 Medizinische Klinik V, Universitätsklinikum Heidelberg and Nationales Centrum für Tumorerkrankungen, Heidelberg, Germany
- Niels W.C.J. van de Donk
- 9 9Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
- Enrique Ocio
- 10 Hospital Universitario Marqués de Valdecilla (IDIVAL) Universidad de Cantabria, Santander, Spain
- Joaquín Martinez-Lopez
- 11 Hematología Hospital 12 de Octubre, Madrid, Spain
- Paula Rodríguez-Otero
- 12 Clínica Universidad de Navarra, CIMA, CIBERONC, IDISNA, Pamplona, Spain
- Dominik Dytfeld
- 13 Poznan University of Medical Sciences, Poznan, Poland
- Joris Diels
- 14 Janssen Pharmaceutica NV, Beerse, Belgium
- Vadim Strulev
- 14 Janssen Pharmaceutica NV, Beerse, Belgium
- Imene Haddad
- 15 Janssen-Cilag, Moulineaux, France
- Thomas Renaud
- 16 Janssen Research & Development, Raritan, United States
- Eric Ammann
- 17 Janssen Global Services, Raritan, United States
- Jedelyn Cabrieto
- 14 Janssen Pharmaceutica NV, Beerse, Belgium
- Nolen Perualila
- 14 Janssen Pharmaceutica NV, Beerse, Belgium
- Ryan Gan
- 18 Janssen Research & Development, Brisbane, United States
- Youyi Zhang
- 16 Janssen Research & Development, Raritan, United States
- Trilok Parekh
- 19 Janssen Research & Development, Bridgewater, United States
- Claire Albrecht
- 20 Janssen Global Services, Paris, France
- Katja Weisel
- 21 University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- Maria-Victoria Mateos
- 22 University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain
- DOI
- https://doi.org/10.1097/01.HS9.0000970596.51835.28
- Journal volume & issue
-
Vol. 7
p. e5183528
Abstract
No abstracts available.